A61K36/532

HERBAL COMPOSITION, PREPARATION METHOD THEREOF AND METHOD FOR PREVENTING OR TREATING RESPIRATORY DISORDER BY ADMINISTERING THE SAME
20230149494 · 2023-05-18 ·

Provided is an herbal composition including an extract from a combination of herbs including at least five of Forsythia suspensa, Scutellaria baicalensis, Bupleurum chinese, Magnolia officinalis, Agastache rugosa, Astragalus membranaceus, Atractylodes macrocephala, and seeds of Ligustrum lucidum. Also provided is a method for preparing the herbal composition and a method for preventing or treating a viral infection by administering an effective amount of the herbal composition to a subject in need thereof.

HERBAL COMPOSITION, PREPARATION METHOD THEREOF AND METHOD FOR PREVENTING OR TREATING RESPIRATORY DISORDER BY ADMINISTERING THE SAME
20230149494 · 2023-05-18 ·

Provided is an herbal composition including an extract from a combination of herbs including at least five of Forsythia suspensa, Scutellaria baicalensis, Bupleurum chinese, Magnolia officinalis, Agastache rugosa, Astragalus membranaceus, Atractylodes macrocephala, and seeds of Ligustrum lucidum. Also provided is a method for preparing the herbal composition and a method for preventing or treating a viral infection by administering an effective amount of the herbal composition to a subject in need thereof.

HERBAL COMPOSITION, PREPARATION METHOD THEREOF AND METHOD FOR PREVENTING OR TREATING RESPIRATORY DISORDER BY ADMINISTERING THE SAME
20230149494 · 2023-05-18 ·

Provided is an herbal composition including an extract from a combination of herbs including at least five of Forsythia suspensa, Scutellaria baicalensis, Bupleurum chinese, Magnolia officinalis, Agastache rugosa, Astragalus membranaceus, Atractylodes macrocephala, and seeds of Ligustrum lucidum. Also provided is a method for preparing the herbal composition and a method for preventing or treating a viral infection by administering an effective amount of the herbal composition to a subject in need thereof.

UCP-1 expression promoter
10758519 · 2020-09-01 · ·

It is intended to provide a drug, a quasi-drug, a dermatological preparation for external use, or a material to be contained to drugs, quasi-drugs, dermatological preparations for external use, food products, or the like which has an excellent UCP-1 expression-promoting action and promotes conversion of adipose to brown adipose (browning). The present invention provides a UCP-1 expression promoter comprising a PPAR activator and a Smad3 inhibitor in combination. The present invention also provides a UCP-1 expression promoter comprising a PPAR activator, a Smad3 inhibitor, and a 3 adrenaline receptor activator or a TGR5 activator in combination.

UCP-1 expression promoter
10758519 · 2020-09-01 · ·

It is intended to provide a drug, a quasi-drug, a dermatological preparation for external use, or a material to be contained to drugs, quasi-drugs, dermatological preparations for external use, food products, or the like which has an excellent UCP-1 expression-promoting action and promotes conversion of adipose to brown adipose (browning). The present invention provides a UCP-1 expression promoter comprising a PPAR activator and a Smad3 inhibitor in combination. The present invention also provides a UCP-1 expression promoter comprising a PPAR activator, a Smad3 inhibitor, and a 3 adrenaline receptor activator or a TGR5 activator in combination.

UCP-1 expression promoter
10758519 · 2020-09-01 · ·

It is intended to provide a drug, a quasi-drug, a dermatological preparation for external use, or a material to be contained to drugs, quasi-drugs, dermatological preparations for external use, food products, or the like which has an excellent UCP-1 expression-promoting action and promotes conversion of adipose to brown adipose (browning). The present invention provides a UCP-1 expression promoter comprising a PPAR activator and a Smad3 inhibitor in combination. The present invention also provides a UCP-1 expression promoter comprising a PPAR activator, a Smad3 inhibitor, and a 3 adrenaline receptor activator or a TGR5 activator in combination.

Composition comprising natural complex extract as active ingredient

The present invention relates to a composition comprising a natural complex extract. It is confirmed that the composition has synergistic effects on antioxidant activity, immune enhancement, whitening, anti-wrinkle and collagenase inhibition with low cytotoxicity, and therefore, the composition is suitable for uses of antioxidation, immune, whitening and skin anti-wrinkle.

Composition comprising natural complex extract as active ingredient

The present invention relates to a composition comprising a natural complex extract. It is confirmed that the composition has synergistic effects on antioxidant activity, immune enhancement, whitening, anti-wrinkle and collagenase inhibition with low cytotoxicity, and therefore, the composition is suitable for uses of antioxidation, immune, whitening and skin anti-wrinkle.

Solid drink for regulating phlegm-dampness constitution and processing method thereof
10406195 · 2019-09-10 ·

A solid drink includes the following components of raw materials in parts by weight: kudzu vine root 25-60 parts, nutmeg 13-35 parts, fructus perillae 30-50 parts, radish seed 34-53 parts, dried tangerine peel 28-55 parts, poria 27-52 parts, fructus amomi 4-15 parts, malt 26-50 parts, agastache rugosa 14-33 parts, kelp 24-51 parts, semen coicis 22-40 parts, dextrin 50-90 parts, maltodextrin 38-70 parts, soluble starch 35-70 parts, and aspartame 0.1-0.5 parts.

Solid drink for regulating phlegm-dampness constitution and processing method thereof
10406195 · 2019-09-10 ·

A solid drink includes the following components of raw materials in parts by weight: kudzu vine root 25-60 parts, nutmeg 13-35 parts, fructus perillae 30-50 parts, radish seed 34-53 parts, dried tangerine peel 28-55 parts, poria 27-52 parts, fructus amomi 4-15 parts, malt 26-50 parts, agastache rugosa 14-33 parts, kelp 24-51 parts, semen coicis 22-40 parts, dextrin 50-90 parts, maltodextrin 38-70 parts, soluble starch 35-70 parts, and aspartame 0.1-0.5 parts.